KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palvella Therapeutics (PVLA) Curent Deferred Tax Liability: 2013-2015

Historic Curent Deferred Tax Liability for Palvella Therapeutics (PVLA) over the last 1 years, with Sep 2015 value amounting to $24,464.

  • Palvella Therapeutics' Curent Deferred Tax Liability was N/A to $24,464 in Q3 2015 from the same period last year, while for Sep 2015 it was $24,464, marking a year-over-year change of. This contributed to the annual value of $26,522 for FY2014, which is 40.50% up from last year.
  • Latest data reveals that Palvella Therapeutics reported Curent Deferred Tax Liability of $24,464 as of Q3 2015, which was up 0.07% from $24,446 recorded in Q2 2015.
  • In the past 5 years, Palvella Therapeutics' Curent Deferred Tax Liability registered a high of $26,522 during Q4 2014, and its lowest value of $18,877 during Q4 2013.
  • In the last 3 years, Palvella Therapeutics' Curent Deferred Tax Liability had a median value of $24,446 in 2015 and averaged $23,570.
  • Data for Palvella Therapeutics' Curent Deferred Tax Liability shows a peak YoY skyrocketed of 40.50% (in 2014) over the last 5 years.
  • Over the past 3 years, Palvella Therapeutics' Curent Deferred Tax Liability (Quarterly) stood at $18,877 in 2013, then soared by 40.50% to $26,522 in 2014, then reached $24,464 in 2015.
  • Its Curent Deferred Tax Liability stands at $24,464 for Q3 2015, versus $24,446 for Q2 2015 and $23,541 for Q1 2015.